Build, co-develop, or own – on your terms.

An exploratory conversation with our partnership team to surface your market opportunity, target indication, geography, regulatory ambition and preferred engagement model – white-label, co-development or exclusive territory.

Our scientists co-define the Target Product Profile with you – dosage form, claim architecture, intended market(s), regulatory pathway and benchmark molecules. Stability, microbial and analytical scopes are framed.

R&D hands over a partner-grade tech package – bench formulation, in-vitro performance, prototype samples, analytical methods (ICH Q2-aligned) and stability protocols against the chosen pharmacopoeial frame.

Pilot-scale manufacturing under cGMP, supported by full microbial and stability sampling. Process robustness is mapped, packaging is finalized and a release-test plan is locked in.

Lab-to-plant transfer is executed at Stabicon's manufacturing facility or a nominated partner site, with parallel preparation of regulatory dossier modules and submission readiness.

Commercial release across your geographies, with ongoing stability monitoring, post-launch quality coordination and a lifecycle plan that opens room for line extensions, new formats and adjacent indications.